![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Saturday, June 06, 2020 6:29:55 PM
Kati Kebbel
Head of Department GMP Cell and Gene Therapy at Fraunhofer Institute for Cell Therapy and Immunology
Consultant
Northwest Biotherapeutics GmbH
Dates Employed Oct 2013 – Dec 2016
Employment Duration 3 yrs 3 mos
Location Leipzig
Consultant
Key words: qualified person acc. to §15 German Drug Act (AMG); supporting QC and QA related tasks
https://www.linkedin.com/in/kati-kebbel-9654978b/
Gerno Schmiedeknecht
Head of Main Department GMP Cell and Gene Therapy at Fraunhofer Institute for Cell Therapy and Immunology IZI
Regulatory Consultant and Qualified Person
Northwest Biotherapeutics GmbH
Dates Employed Oct 2013 – Dec 2016
Employment Duration 3 yrs 3 mos
Location Leipzig
Qualified Person (QP) according to §15, section 3a, point 1 & 2 German Drug Act. Regulatory consultancy cell therapy manufacturing, quality control and supply.
https://www.linkedin.com/in/gerno-schmiedeknecht-9a289850/
Günter Rosskamp
CEO bei Northwest Biotherapeutics GmbH
Amtsgericht Leipzig Aktenzeichen: HRB 27978 Bekannt gemacht am: 30.11.2016 18:30 Uhr
Die in () gesetzten Angaben der Geschäftsanschrift und des Unternehmensgegenstandes erfolgen ohne Gewähr.
Veränderungen
30.11.2016
HRB 27978: Northwest Biotherapeutics GmbH, Leipzig, Deutscher Platz 5, 04103 Leipzig. Ausgeschieden: Geschäftsführer: Dr. Rosskamp, Guenter, Berlin, *04.06.1942.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156101950
…. and December 15, 2016- famous presentation by Linda Liau-
Recent NWBO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/30/2024 11:49:38 PM
- Biophma Announces Exclusive In License for Dendritic Cell Technology, Sending Shares Higher • AllPennyStocks.com • 06/17/2024 04:40:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 09:11:16 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 06/03/2024 09:22:55 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/22/2024 08:13:36 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 09:04:57 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/01/2024 10:04:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/02/2023 01:31:35 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 10:11:54 PM
- Epazz, Inc. (OTC Pink: EPAZ) ZenaDrone Demonstration to Defense Departments of UAE and Saudi Arabia • InvestorsHub NewsWire • 11/15/2023 12:19:31 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 09:30:39 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 • InvestorsHub NewsWire • 11/09/2023 01:00:34 PM
- Epazz, Inc. (OTC Pink: EPAZ) US Navy Collaboration ZenaDrone 1000 Extreme Weather Demo • InvestorsHub NewsWire • 11/07/2023 12:29:43 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/09/2023 08:36:14 PM
Duane Forrester Joins INDEXR as SVP of Search • MONI • Jul 31, 2024 11:46 AM
Lingerie Fighting Championships Help Fulfill Death-Bed Promise With First Major Motion Picture • BOTY • Jul 31, 2024 9:00 AM
Kona Gold Beverage Significantly Reduces Debt from Multiple Holders • KGKG • Jul 31, 2024 9:00 AM
Avant Technologies Opens Equity Line with GHS Investments as Company Explores Expansion into Additional Technologies • AVAI • Jul 30, 2024 8:00 AM
ELEMENT79 GOLD CORP PROVIDES UPDATE ON CHACHAS COMMUNITY CHARTER AND REVENUE GENERATION, M&A ACTIVITIES • ELMGF • Jul 30, 2024 8:00 AM
INDEXR AI Merges With Moon Equity Holdings Corp. (MONI), Creating a Leading-edge Technology Company • MONI • Jul 29, 2024 9:59 AM